AUROSCIENCE PTY LTD MELBOURNE
Aurobindo Pharma inks pact to acquire Australian pharma firm's productBased out of Melbourne, Advent Pharmaceuticals is engaged in developing and commercialising generic inhaled medicines for global markets.
Aurobindo Pharma to acquire under development product, related assets from Advent for $12.5mnThe acquisition is for a cash consideration of USD 12.5 million, it added. The indicative time period for completion of the acquisition is ...
- Load More